Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples

Journal of Proteome Research

Volumn 11, Issue 7, 2012, Pages 3880-3887

  Martínez Morillo, Eduardo ^a   Cho, Chan Kyung J ^a   Drabovich, Andrei P ^a   Shaw, Julie L V ^a,b,c   Soosaipillai, Antoninus ^b   Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

amniotic fluid; biomarker; CEL; CLCA1; CPA1; Down's syndrome; HAPLN1; MUC13; MUC5AC

Indexed keywords

BILE SALT ACTIVATED LIPASE; BIOCHEMICAL MARKER; CARBOXYPEPTIDASE A1; CHLORIDE CHANNEL ACCESSORY 1 PROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 1; MUCIN 13; MUCIN 5AC; PALATE, LUNG AND NASAL EPITHELIUM ASSOCIATED PROTEIN; SEROTRANSFERRIN; UNCLASSIFIED DRUG;

AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; ARTICLE; ASSAY; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC TEST; DOWN SYNDROME; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MULTIPLEX SELECTED REACTION MONITORING ASSAY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AMNIOCENTESIS; AMNIOTIC FLUID; AREA UNDER CURVE; BIOLOGICAL MARKERS; CARBOXYPEPTIDASES A; CASE-CONTROL STUDIES; CHLORIDE CHANNELS; DOWN SYNDROME; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; LIPASE; MUCIN 5AC; MUCINS; PHOSPHOPROTEINS; PREGNANCY; PROTEOGLYCANS; ROC CURVE; TANDEM MASS SPECTROMETRY;

EID: 84863622626     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300355a     Document Type: Article

References (36)

1. Megarbane, A.; Ravel, A.; Mircher, C.; Sturtz, F.; Grattau, Y.; Rethore, M. O.; Delabar, J. M.; Mobley, W. C. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome Genet. Med. 2009, 11 (9) 611-6
2. Roizen, N. J.; Patterson, D. Down's syndrome Lancet 2003, 361 (9365) 1281-9 (Pubitemid 36428586)
3. Yang, Q.; Rasmussen, S. A.; Friedman, J. M. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study Lancet 2002, 359 (9311) 1019-25 (Pubitemid 34286539)
4. Nicolaides, K. H. Screening for fetal aneuploidies at 11 to 13 weeks Prenatal Diagn. 2011, 31 (1) 7-15
5. Mujezinovic, F.; Alfirevic, Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review Obstet. Gynecol. 2007, 110 (3) 687-94 (Pubitemid 47359597)
6. Drabovich, A. P.; Pavlou, M. P.; Dimitromanolakis, A.; Diamandis, E. P. Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay Mol. Cell. Proteomics 2012, 11 (7) M111015214
7. Drabovich, A. P.; Jarvi, K.; Diamandis, E. P. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay Mol. Cell. Proteomics 2011, 10 (12) M110004127
8. Gallien, S.; Duriez, E.; Domon, B. Selected reaction monitoring applied to proteomics J. Mass Spectrom. 2011, 46 (3) 298-312
9. Tisi, D. K.; Emard, J. J.; Koski, K. G. Total protein concentration in human amniotic fluid is negatively associated with infant birth weight J. Nutr. 2004, 134 (7) 1754-8 (Pubitemid 38886565)
10. Cho, C. K.; Diamandis, E. P. Application of proteomics to prenatal screening and diagnosis for aneuploidies Clin. Chem. Lab. Med. 2011, 49 (1) 33-41
11. Cho, C. K.; Drabovich, A. P.; Batruch, I.; Diamandis, E. P. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay J. Proteomics 2011, 74 (10) 2052-9
12. Cho, C. K.; Smith, C. R.; Diamandis, E. P. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery J. Proteome Res. 2010, 9 (7) 3574-82
13. Hortin, G. L.; Sviridov, D.; Anderson, N. L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance Clin. Chem. 2008, 54 (10) 1608-16
14. Wu, C.; Orozco, C.; Boyer, J.; Leglise, M.; Goodale, J.; Batalov, S.; Hodge, C. L.; Haase, J.; Janes, J.; Huss, J. W., 3rd; Su, A. I. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources Genome Biol. 2009, 10 (11) R130
15. Uhlen, M.; Oksvold, P.; Fagerberg, L.; Lundberg, E.; Jonasson, K.; Forsberg, M.; Zwahlen, M.; Kampf, C.; Wester, K.; Hober, S.; Wernerus, H.; Bjorling, L.; Ponten, F. Towards a knowledge-based Human Protein Atlas Nat. Biotechnol. 2010, 28 (12) 1248-50
16. Camacho, C.; Coulouris, G.; Avagyan, V.; Ma, N.; Papadopoulos, J.; Bealer, K.; Madden, T. L. BLAST+: architecture and applications BMC Bioinf. 2009, 10, 421
17. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-8
18. Go, A. T.; van Vugt, J. M.; Oudejans, C. B. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities Hum. Reprod. Update 2011, 17 (3) 372-82
19. Palomaki, G. E.; Kloza, E. M.; Lambert-Messerlian, G. M.; Haddow, J. E.; Neveux, L. M.; Ehrich, M.; van den Boom, D.; Bombard, A. T.; Deciu, C.; Grody, W. W.; Nelson, S. F.; Canick, J. A. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet. Med. 2011, 13 (11) 913-20
20. Heywood, W.; Wang, D.; Madgett, T. E.; Avent, N. D.; Eaton, S.; Chitty, L. S.; Mills, K. The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome J. Proteomics 2012, 75 (11) 3248-57
21. Lopez, M. F.; Kuppusamy, R.; Sarracino, D. A.; Prakash, A.; Athanas, M.; Krastins, B.; Rezai, T.; Sutton, J. N.; Peterman, S.; Nicolaides, K. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum J. Proteome Res. 2011, 10 (1) 133-42
22. Kang, Y.; Dong, X.; Zhou, Q.; Zhang, Y.; Cheng, Y.; Hu, R.; Su, C.; Jin, H.; Liu, X.; Ma, D.; Tian, W.; Li, X. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis Prenatal Diagn. 2012, 32 (3) 284-92
23. Kolla, V.; Jeno, P.; Moes, S.; Tercanli, S.; Lapaire, O.; Choolani, M.; Hahn, S. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ) J. Biomed. Biotechnol. 2010, 952047
24. Weijerman, M. E.; de Winter, J. P. Clinical practice. The care of children with Down syndrome Eur. J. Pediatr. 2010, 169 (12) 1445-52
25. Spencer, K.; Muller, F.; Aitken, D. A. Biochemical markers of trisomy 21 in amniotic fluid Prenatal Diagn. 1997, 17 (1) 31-7 (Pubitemid 27046249)
26. Wirrig, E. E.; Snarr, B. S.; Chintalapudi, M. R.; O'Neal, J, L.; Phelps, A. L.; Barth, J. L.; Fresco, V. M.; Kern, C. B.; Mjaatvedt, C. H.; Toole, B. P.; Hoffman, S.; Trusk, T. C.; Argraves, W. S.; Wessels, A. Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development Dev. Biol. 2007, 310 (2) 291-303 (Pubitemid 47483684)
27. Cheek, J. D.; Wirrig, E. E.; Alfieri, C. M.; James, J. F.; Yutzey, K. E. Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease J. Mol. Cell. Cardiol. 2012, 52 (3) 689-700
28. Liu, J.; Park, E. S.; Curry, T. E., Jr.; Jo, M. Periovulatory expression of hyaluronan and proteoglycan link protein 1 (Hapln1) in the rat ovary: hormonal regulation and potential function Mol. Endocrinol. 2010, 24 (6) 1203-17
29. Perez-Vilar, J.; Randell, S. H.; Boucher, R. C. C-Mannosylation of MUC5AC and MUC5B Cys subdomains Glycobiology 2004, 14 (4) 325-37 (Pubitemid 38628110)
30. Ali, M. S.; Pearson, J. P. Upper airway mucin gene expression: a review Laryngoscope 2007, 117 (5) 932-8 (Pubitemid 46699374)
31. Winpenny, J. P.; Marsey, L. L.; Sexton, D. W. The CLCA gene family: putative therapeutic target for respiratory diseases Inflammation Allergy: Drug Targets 2009, 8 (2) 146-60
32. Kim, Y. M.; Won, T. B.; Kim, S. W.; Min, Y. G.; Lee, C. H.; Rhee, C. S. Histamine induces MUC5AC expression via a hCLCA1 pathway Pharmacology 2007, 80 (4) 219-26 (Pubitemid 47557255)
33. Kim, S. H.; Krapfenbauer, K.; Cheon, M. S.; Fountoulakis, M.; Cairns, N. J.; Lubec, G. Human brain cytosolic histamine- N -methyltransferase is decreased in Down syndrome and increased in Pick's disease Neurosci. Lett. 2002, 321 (3) 169-72 (Pubitemid 34203826)
34. Maher, D. M.; Gupta, B. K.; Nagata, S.; Jaggi, M.; Chauhan, S. C. Mucin 13: structure, function, and potential roles in cancer pathogenesis Mol. Cancer Res. 2011, 9 (5) 531-7
35. Hui, D. Y.; Hayakawa, K.; Oizumi, J. Lipoamidase activity in normal and mutagenized pancreatic cholesterol esterase (bile salt-stimulated lipase) Biochem. J. 1993, 291 (Pt 1) 65-9 (Pubitemid 23107750)
36. Bocconi, L.; Nava, S.; Fogliani, R.; Nicolini, U. Trisomy 21 is associated with hypercholesterolemia during intrauterine life Am. J. Obstet. Gynecol. 1997, 176 (3) 540-3 (Pubitemid 27147158)